Kallikrein-inhibitor therapies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9114144
APP PUB NO 20120015881A1
SERIAL NO

13228300

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • DYAX CORP.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bergamaschini, Luigi Milan, IT 10 352
Grazia, De Simoni Maria Milan, IT 1 13
Hirani, Shirish Arlington, US 23 760
Ladner, Robert C Ijamsville, US 96 10162
Ley, Arthur C Newton, US 42 5758
Williams, Anthony Melrose, US 54 1040

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00